Mercer Global Advisors’s Inspire Medical Systems INSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.11M Buy
24,944
+18,967
+317% +$900K ﹤0.01% 1669
2026
Q1
$308K Buy
+5,977
New +$418K ﹤0.01% 2399
2025
Q1
Sell
-1,643
Closed -$305K 2209
2024
Q4
$305K Sell
1,643
-641
-28% -$124K ﹤0.01% 1735
2024
Q3
$478K Buy
+2,284
New +$397K ﹤0.01% 1357
2024
Q2
Sell
-2,433
Closed -$523K 2002
2024
Q1
$523K Sell
2,433
-178
-7% -$34.9K ﹤0.01% 1255
2023
Q4
$531K Buy
2,611
+600
+30% +$97.2K ﹤0.01% 1288
2023
Q3
$399K Buy
2,011
+889
+79% +$224K ﹤0.01% 1365
2023
Q2
$364K Buy
1,122
+42
+4% +$12K ﹤0.01% 1396
2023
Q1
$253K Buy
1,080
+179
+20% +$45.2K ﹤0.01% 1607
2022
Q4
$227K Buy
+901
New +$192K ﹤0.01% 1643

Other funds holding INSP

Mercer Global Advisors's INSP Position: Q2 2026 in Review

Mercer Global Advisors increased its Inspire Medical Systems (INSP) stake by 317% in Q2 2026, buying an estimated $900K and bringing the position to 24,944 shares worth $1.11M. The position accounts for ﹤0.01% of the portfolio, ranked #1669.

Mercer Global Advisors first reported a position in INSP in Q4 2022 and has held it in 10 quarters since. 275 funds tracked by Wall St. Rank hold INSP as of Q2 2026.

  • Mercer Global Advisors held 24,944 shares of Inspire Medical Systems worth $1.11M as of Q2 2026.
  • Mercer Global Advisors bought 18,967 Inspire Medical Systems shares in Q2 2026, an estimated $900K.
  • Inspire Medical Systems made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #1669 holding.
  • Mercer Global Advisors first reported a position in Inspire Medical Systems in Q4 2022 and has held it in 10 quarters since.
  • 275 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.